BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19997062)

  • 1. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.
    Woltjen K; Michael IP; Mohseni P; Desai R; Mileikovsky M; Hämäläinen R; Cowling R; Wang W; Liu P; Gertsenstein M; Kaji K; Sung HK; Nagy A
    Nature; 2009 Apr; 458(7239):766-70. PubMed ID: 19252478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming of adult human testicular cells by four transcription factors (OCT4, SOX2, KLF4, and C-MYC).
    Kobayashi H; Nakajima K; Oka Y; Tai T; Nagao K; Ishii N
    Reprod Med Biol; 2011 Jun; 10(2):105-112. PubMed ID: 29699086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels.
    Margariti A; Winkler B; Karamariti E; Zampetaki A; Tsai TN; Baban D; Ragoussis J; Huang Y; Han JD; Zeng L; Hu Y; Xu Q
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13793-8. PubMed ID: 22869753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterministic versus stochastic model of reprogramming: new evidence from cellular barcoding technique.
    Yunusova AM; Fishman VS; Vasiliev GV; Battulin NR
    Open Biol; 2017 Apr; 7(4):. PubMed ID: 28446707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.
    Hockemeyer D; Soldner F; Cook EG; Gao Q; Mitalipova M; Jaenisch R
    Cell Stem Cell; 2008 Sep; 3(3):346-353. PubMed ID: 18786421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iPS Cells-The Triumphs and Tribulations.
    Sharma R
    Dent J (Basel); 2016 Jun; 4(2):. PubMed ID: 29563461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells as a cellular model for studying Down Syndrome.
    Brigida AL; Siniscalco D
    J Stem Cells Regen Med; 2016; 12(2):54-60. PubMed ID: 28096629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.
    Ohm JE; Mali P; Van Neste L; Berman DM; Liang L; Pandiyan K; Briggs KJ; Zhang W; Argani P; Simons B; Yu W; Matsui W; Van Criekinge W; Rassool FV; Zambidis E; Schuebel KE; Cope L; Yen J; Mohammad HP; Cheng L; Baylin SB
    Cancer Res; 2010 Oct; 70(19):7662-73. PubMed ID: 20841480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-based cancer cell reprogramming technology.
    Nishikawa S; Ishii H; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Ozaki M; Dewi DL; Sakai D; Satoh T; Nagano H; Doki Y; Mori M
    Exp Ther Med; 2012 Jul; 4(1):8-14. PubMed ID: 23060915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avian iPSC Derivation to Recover Threatened Wild Species: A Comprehensive Review in Light of Well-Established Protocols.
    Nogueira IPM; Costa GMJ; Lacerda SMDSN
    Animals (Basel); 2024 Jan; 14(2):. PubMed ID: 38254390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevating Growth Factor Responsiveness and Axon Regeneration by Modulating Presynaptic Inputs.
    Zhang Y; Williams PR; Jacobi A; Wang C; Goel A; Hirano AA; Brecha NC; Kerschensteiner D; He Z
    Neuron; 2019 Jul; 103(1):39-51.e5. PubMed ID: 31122676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells.
    D'Aiuto L; Di Maio R; Heath B; Raimondi G; Milosevic J; Watson AM; Bamne M; Parks WT; Yang L; Lin B; Miki T; Mich-Basso JD; Arav-Boger R; Sibille E; Sabunciyan S; Yolken R; Nimgaonkar V
    PLoS One; 2012; 7(11):e49700. PubMed ID: 23209593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient division and sampling of cell colonies using microcup arrays.
    Pai JH; Kluckman K; Cowley DO; Bortner DM; Sims CE; Allbritton NL
    Analyst; 2013 Jan; 138(1):220-8. PubMed ID: 23099535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-chromosome inactivation in monkey embryos and pluripotent stem cells.
    Tachibana M; Ma H; Sparman ML; Lee HS; Ramsey CM; Woodward JS; Sritanaudomchai H; Masterson KR; Wolff EE; Jia Y; Mitalipov SM
    Dev Biol; 2012 Nov; 371(2):146-55. PubMed ID: 22935618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte marker expression in a human lymphocyte cell line using mouse cardiomyocyte extract.
    Vojdani Z; Tavakolinejad S; Talaei-Khozani T; Esmaeilpour T; Rasooli M
    Hum Cell; 2011 Mar; 24(1):35-42. PubMed ID: 21547694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined epigenetic and non-genetic approach for reprogramming human somatic cells.
    Han J; Sachdev PS; Sidhu KS
    PLoS One; 2010 Aug; 5(8):e12297. PubMed ID: 20808872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cells by reprogramming human fibroblasts with the stemgent human TF lentivirus set.
    Wu D; Hamilton B; Martin C; Gao Y; Ye M; Yao S
    J Vis Exp; 2009 Dec; (34):. PubMed ID: 19997062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells by reprogramming mouse embryonic fibroblasts with a four transcription factor, doxycycline inducible lentiviral transduction system.
    Hamilton B; Feng Q; Ye M; Welstead GG
    J Vis Exp; 2009 Nov; (33):. PubMed ID: 19915522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
    Brambrink T; Foreman R; Welstead GG; Lengner CJ; Wernig M; Suh H; Jaenisch R
    Cell Stem Cell; 2008 Feb; 2(2):151-9. PubMed ID: 18371436
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.